CUL5 and prostate carcinoma: Its involvement includes the promotion of cell migration, invasion, and EMT in prostate cancer by directly binding to Cullin-5 (CUL5) mRNA 3′-UTR as reported by Wang et al. [85]; the regulation of proliferation and apoptosis of prostate cancer cells by targeting the B cell translocation gene 1 (BTG1) as described by Lu et al. [86], and the inhibition of vacuolar protein sorting-associated protein 37A (VPS37A) expression, as indicated by Fu et al. [87].